Followers | 195 |
Posts | 24572 |
Boards Moderated | 0 |
Alias Born | 04/03/2010 |
Thursday, December 09, 2021 4:18:06 PM
They never say it, but the entire story of that company, maybe a promising technology and story, it just disappears.
My experience is with Japanese companies buying out companies in particular. Patents are really useful, developing some random drug a company may have wished to develop with it, costs money and may not have been the strategic reason the company was bought.
But for people, doctors, patients, investors, caught up in the idea that they were solving a major health problem, it's a disappointment, but seems to be easily forgotten in the cash payment. Most people move on, as I have in those circumstances. If you made money, you made money. If management was willing to sell out, fine. And more frequently, the sale is due to trauma in the c-suite. Shorts go after key people, they end up falling into some spiral of bad press, and leave or get jettisoned, but they were a key person behind the tech. And then a sale becomes the obvious option. A large Pharma comes in, buys it saying they look forward to keeping it all going, blah blah blah, and you never hear about that technology again. They bought it for the patents, and like that Indiana Jones vignette at the end, it may or may never really get much use again as big companies are not very efficient at deploying their assets to all possible opportunities. They prioritize, and manage, and limit. But they also have patents that they can then use in a variety of ways, sometimes defensively, and sometimes to add to other things they are doing.
Recent NWBO News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM